Wichmann Johnson

  • Based on
    zantac recall from laboratory testing, the U.S. FDA has learned that Zantac® and other ranitidine medications contain a nitrosamine impurity called N–nitrosodimethylamine (NDMA) at low levels. NDMA is considered as a probable human carcinogen – a substance might cause cancer in humans. NDMA is a known environmental contaminant and obs…[閱讀更多]

  • Seen from results from laboratory testing, the U.S. Food and Drug Administration has learned that Zantac® and various ranitidine based medicines contain a nitrosamine issue called N–nitrosodimethylamine (NDMA) at lower amounts. NDMA is considered as a likely human carcinogen – a substance might cause cancer in humans. NDMA is a known env…[閱讀更多]

  • Wichmann Johnson 成為已註冊的成員 1 月, 1 週前